OrbiMed's Biopharma Portfolio

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.